Department of HIV/AIDS, National Institute for Research in Tuberculosis (ICMR), Chennai, India.
Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Front Immunol. 2019 Aug 27;10:1965. doi: 10.3389/fimmu.2019.01965. eCollection 2019.
The ART program in low- and middle-income countries (LMIC) like India, follows a public health approach with a standardized regimen for all people living with HIV (PLHIV). Based on the evidence from high-income countries (HIC), the risk of an enhanced, and accentuated onset of premature-aging or age-related diseases has been observed in PLHIV. However, very limited data is available on residual inflammation and immune activation in the populations who are on first-generation anti-HIV drugs like zidovudine and lamivudine that have more toxic side effects. Therefore, the aim of the present study was to evaluate the levels of systemic inflammation and understand the risk of age-associated diseases in PLHIV on long-term suppressive ART using a large number of biomarkers of inflammation and immune activation. Blood samples were obtained from therapy naïve PLHIV (Pre-ART, = 43), PLHIV on ART for >5 years (ART, = 53), and HIV-negative healthy controls (HIVNC, = 41). Samples were analyzed for 92 markers of inflammation, sCD14, sCD163, and telomere length. Several statistical tests were performed to compare the groups under study. Multivariate linear regression was used to investigate the associations. Despite a median duration of 8 years of successful ART, sCD14 ( < 0.001) and sCD163 ( = 0.04) levels continued to be significantly elevated in ART group as compared to HIVNC. Eleven inflammatory markers, including 4E-BP1, ADA, CCL23, CD5, CD8A, CST5, MMP1, NT3, SLAMF1, TRAIL, and TRANCE, were found to be significantly different ( < 0.05) between the groups. Many of these markers are associated with age-related co-morbidities including cardiovascular disease, neurocognitive decline and some of these markers are being reported for the first time in the context of HIV-induced inflammation. Linear regression analysis showed a significant negative association between HIV-1-positivity and telomere length ( < 0.0001). In ART-group CXCL1 ( = 0.048) and TGF-α ( = 0.026) showed a significant association with the increased telomere length and IL-10RA was significantly associated with decreased telomere length ( = 0.042). This observation warrants further mechanistic studies to generate evidence to highlight the need for enhanced treatment monitoring and special interventions in HIV-infected individuals.
在印度等中低收入国家(LMIC),ART 项目采用公共卫生方法,为所有 HIV 感染者(PLHIV)提供标准化治疗方案。基于高收入国家(HIC)的证据,人们观察到 PLHIV 中增强和加重的早逝或与年龄相关疾病的发病风险。然而,关于第一代抗 HIV 药物(如齐多夫定和拉米夫定)治疗人群中残留炎症和免疫激活的数据非常有限,这些药物具有更多的毒性副作用。因此,本研究旨在评估系统炎症水平,并使用大量炎症和免疫激活生物标志物了解 PLHIV 在长期抑制性 ART 治疗下与年龄相关疾病的风险。从未经治疗的 PLHIV(Pre-ART,n = 43)、接受 ART 治疗超过 5 年的 PLHIV(ART,n = 53)和 HIV 阴性健康对照(HIVNC,n = 41)中获得血液样本。分析了 92 种炎症标志物、sCD14、sCD163 和端粒长度。进行了多项统计检验以比较研究组。多变量线性回归用于研究相关性。尽管 ART 治疗中位时间为 8 年,但与 HIVNC 相比,ART 组的 sCD14(<0.001)和 sCD163(=0.04)水平仍显著升高。11 种炎症标志物,包括 4E-BP1、ADA、CCL23、CD5、CD8A、CST5、MMP1、NT3、SLAMF1、TRAIL 和 TRANCE,在组间差异有统计学意义(<0.05)。其中许多标志物与心血管疾病、神经认知能力下降等与年龄相关的合并症有关,其中一些标志物是首次在 HIV 诱导的炎症背景下报道的。线性回归分析显示,HIV-1 阳性与端粒长度呈显著负相关(<0.0001)。在 ART 组中,CXCL1(=0.048)和 TGF-α(=0.026)与端粒长度增加呈显著相关,而 IL-10RA 与端粒长度减少呈显著相关(=0.042)。这一观察结果需要进一步的机制研究来提供证据,以强调需要加强对 HIV 感染者的治疗监测和特殊干预。
J Clin Endocrinol Metab. 2022-1-1
AIDS Patient Care STDS. 2014-6-10
Psychoneuroendocrinology. 2020-8
Front Syst Biol. 2023-2-27
J Natl Compr Canc Netw. 2025-6-9
Front Cardiovasc Med. 2018-12-19
Mediators Inflamm. 2017-10-25